Although the relationship between the GSTM1 null genotype and CYC nephrotoxicity in patients with SLE was confirmed with the subsequent assumption of a similar influence of the same mechanisms on the CYC efficiency, we did not prove the enhanced MTX efficiency in JIA patients through the same presumed mechanism. The gene discussed is GSTM1; the disease is systemic lupus erythematosus.